Who Owns SNOA?

Sonoma Pharmaceuticals, Inc. — Institutional Ownership & 13F Holdings

$1.04

-0.07 (-6.31%)

Market Cap

$4.3M

Shares Outstanding

1,741,420

Institutional Holders

11

Total Inst. Value

$45K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GEODE CAPITAL MANAGEMENT, LLC$36K16,805
2UBS Group AG$4K1,852
3Tower Research Capital LLC (TRC)$3K1,447
4CITIGROUP INC$2K811
5BlackRock, Inc.$247113
6US BANCORP \DE\$5525
7HRT FINANCIAL LP$2511,843
8Allworth Financial LP$123
9MORGAN STANLEY$04
10JPMORGAN CHASE & CO$0138

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
BANK OF AMERICA CORP /DE/+3$0

Top Sellers

FundShares RemovedValue
UBS Group AG-16K$4K
Tower Research Capital LLC (TRC)-960$3K

Related Stocks

Frequently Asked Questions

How many institutional investors hold SNOA?

As of Q1 2025, 11 institutional investors report holding SNOA (Sonoma Pharmaceuticals, Inc.) in their 13F filings.

Which hedge fund owns the most SNOA?

The largest institutional holder of SNOA is GEODE CAPITAL MANAGEMENT, LLC with $36K in shares.

Are institutions buying or selling SNOA?

This quarter, 3 institutions opened new positions in SNOA and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.